CornerCap Investment Counsel »

Deciphera Pharmaceuticals shares owned by CornerCap Investment Counsel

Quarter-by-quarter ownership of Deciphera Pharmaceuticals (DCPH) shares owned by CornerCap Investment Counsel from 13F filings

Historical chart of CornerCap Investment Counsel investment in Deciphera Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Deciphera Pharmaceuticals held by CornerCap Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Deciphera Pharmaceuticals by CornerCap Investment Counsel

Quarter filed Position value Share count Share price at filing
2023-12-31 $269k 17k 16.13
2023-09-30 $170k 13k 12.72

More positions owned by CornerCap Investment Counsel

Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Cisco Systems (CSCO)
Apple (AAPL)
CSX Corporation (CSX)
Microsoft Corporation (MSFT)
Emerson Electric (EMR)
Merck & Co (MRK)
Booking Holdings (BKNG)
Fnf (FNF)
Bristol Myers Squibb (BMY)
Intel Corporation (INTC)

View all positions for CornerCap Investment Counsel

Top funds holding Deciphera Pharmaceuticals

Deerfield Management Company
Redmile Group
Vanguard Group
Goldman Sachs Group
Dimensional Fund Advisors
Braidwell
Frazier Life Sciences Management
Assenagon Asset Management
Emerald Advisers
Millennium Management
Emerald Mutual Fund Advisers, Trust
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Two Sigma Advisers
Jacobs Levy Equity Management

View all funds holding Deciphera Pharmaceuticals